Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial
Chao Sun, Yunpeng Liu, Peng Zhang, Xu Wang, Yinghui Xu, Xingyu Lin, Xiaobo Ma, Ye Guo, Shi Qiu, Guoguang Shao, Zhiguang Yang, Kewei Ma
Topics & Concepts
MedicineCarboplatinInternal medicineChemoimmunotherapyNeoadjuvant therapyOncologyLung cancerClinical endpointChemotherapySurgeryCancerClinical trialCisplatinBreast cancerCyclophosphamideLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical Imaging